Schizophrenia: more dopamine, more D2 receptors.

  title={Schizophrenia: more dopamine, more D2 receptors.},
  author={Philip Seeman and Shitij Kapur},
  journal={Proceedings of the National Academy of Sciences of the United States of America},
  volume={97 14},
S is a major therapeutic challenge of modern medicine, and one of the last frontiers of brain research. The illness is defined by delusions, hallucinations, disorganized behavior, and cognitive difficulties such as memory loss. It occurs in '1% of the world population and usually first appears in early adulthood. Although antipsychotic medications have dramatically improved the lives of patients with schizophrenia, the causes of the illness remain unknown. Of the many contemporary theories of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS